miR-183 as a molecular and protective biomarker for cancer in schizophrenic subjects

Oncology Reports

Volumn 28, Issue 6, 2012, Pages 2200-2204

  Rizos, E ^a   Siafakas, N ^a   Koumarianou, A ^b   Katsantoni, E ^c   Filippopoulou, A ^a   Ntounas, P ^d   Touloumis, Ch ^d   Kastania, A ^c   Zoumpourlis, V ^e  

^a UNIVERSITY OF ATHENS MEDICAL SCHOOL   (Greece)

^b NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS   (Greece)

^c BIOMEDICAL RESEARCH FOUNDATION   (Greece)

^d Psychiatric Hospital of Attika   (Greece)

^e INSTITUTE OF BIOLOGY   (Greece)

Author keywords

Cancer; MicroRNA; MiR 183; Schizophrenia

Indexed keywords

MICRORNA; MICRORNA 183; MOLECULAR MARKER; TUMOR MARKER; UNCLASSIFIED DRUG;

APOPTOSIS; BRAIN NERVE CELL; CANCER CONTROL; CANCER INHIBITION; CANCER RISK; CARCINOGENESIS; CLINICAL ARTICLE; CONFERENCE PAPER; CONTROLLED STUDY; DISEASE ASSOCIATION; DOWN REGULATION; FEMALE; GENE EXPRESSION REGULATION; GENE FUNCTION; HUMAN; MALE; MALIGNANT NEOPLASTIC DISEASE; NEUROBIOLOGY; PRIORITY JOURNAL; RNA ANALYSIS; SCHIZOPHRENIA; SOLID TUMOR; TUMOR SUPPRESSOR GENE;

ADULT; AGED; APOPTOSIS; DOWN-REGULATION; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASMS; SCHIZOPHRENIA; TUMOR MARKERS, BIOLOGICAL;

EID: 84868155247     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2012.2052     Document Type: Conference Paper

References (40)

1. Mortensen PB: The incidence of cancer in schizophrenic patients. J Epidemiol Commun Health 43:43-47, 1989. (Pubitemid 19076739)
2. Lawrence D, Holman CD, Jablenski AV, Threlfall TJ and Fuller SA: Excess cancer mortality in Western Australian psychiatric patients due to higher case fatality rates. Acta Psychiatr Scand 101:382-388, 2000. (Pubitemid 30233004)
3. Barak Y, Achiron A, Mandel M, Mirecki I and Aizenberg D: Reduced cancer incidence among patients with schizophrenia. Cancer 104:2817-2821, 2005. (Pubitemid 41798293)
4. Leucht S, Bunkard T, Henderson J, Maj M and Sartorius N: Physical illness and schizophrenia: a review of the literature. Acta Psychiatr Scand 116:317-333, 2007. (Pubitemid 47537428)
5. Chou FHC, Tsai KY, Su CY and Lee CC: The incidence and relative risk factors for developing cancer among patients with schizophrenia: a nine-year follow-up study. Schizophr Res 129:97-103, 2011.
6. Lin GM, Chen YJ, Kuo DJ, Jaiteh LES, Wu YC, Lo TS and Li YH: Cancer incidence in patients with schizophrenia or bipolar disorder: a nationwide population-based study in Taiwan, 1997-2009. Schizophr Bull 1:1-10, 2011.
7. Fanous AH and Kendler KS: Genetic heterogeneity, modifier genes, and quantitative phenotypses in psychiatric illness: searching for a framework. Mol Psychiatry 10:6-13, 2005.
8. Feinberg AP and Tycko B: The history of cancer epigenetics. Nat Rev Cancer 4:143-153, 2004. (Pubitemid 38198742)
9. Rybakowski JK, Skibinska M, Kapelski P, Kaczmarek L and Hauser J: Functional polymorphism of the matrix metalloproteinase-9 (MMP-9) gene in schizophrenia. Schizophr Res 109:90-93, 2009.
10. Catts VS and Catts SV: Apoptosis and schizophrenia: is the tumour suppressor gene, p53, a candidate susceptibility gene? Schizophr Res 41:405-415, 2000. (Pubitemid 30109597)
11. Bartel DP: MicroRNAs: target recognition and regulatory functions. Cell 136:215-233, 2009.
12. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F and Croce CM: Frequent deletions and down-regulation of micro-RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukaemia. Proc Natl Acad Sci USA 99:15524-15529, 2002. (Pubitemid 35403967)
13. Takamizawa J, Konishi H, Yanagisawa K, Tomida S, Osada H, Endoh H, Harano T, Yatabe Y, Nagino M, Nimura Y, Mitsudomi T and Takahashi T: Reduced expression of the let-7 microRNAs in human lung cancers in association with shortened postoperative survival. Cancer Res 64:3753-3756, 2004. (Pubitemid 38697282)
14. Hansen T, Olsen L, Lindow M, Jakobsen K, Ullum H, Jonsson E, Adreassen O, Djurovic S, Melle I, Agartz I, Hall H, Timm S, Wang AG and Werge T: Brain expressed microRNAs implicated in schizophrenia etiology. Plos One 9:1-7, 2007.
15. Beveridge NJ, Tooney PA, Carroll AP, Gardiner E, Bowden N, Scott RJ, Tran N, Dedova I and Cairns MJ: Dysregulation of miRNA 181b in the temporal cortex in schizophrenia. Human Mol Genet 17:1156-1168, 2008. (Pubitemid 351494187)
16. First MB, Spitzer RL, Gibbon M and William J B M: Structured Clinical Interview for DSM-IV Axis I Disorders. Patient edition. New York State Psychiatric Institute, Biometrics Research, New Yo r k, 1997.
17. Kay SR, Opler LA and Lindenmayer JP: The Positive and Negative Syndrome Scale (PANSS): rational and standardization. Br J Psychiatry 155(Suppl):59-65, 1987.
18. Cui DH, Jiang KD, Jiang SD, Xu YF and Yao H: The tumor suppressor adenomatous polyposis coli gene is associated with susceptibility to schizophrenia. Mol Psychiatry 10:669-677, 2005. (Pubitemid 40961737)
19. Lichtermann D, Ekelund J, Pukkala E, Tanskanen A and Lonnqvist J: Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry 58:573-578, 2001. (Pubitemid 32523737)
20. Dalton SO, Johansen C, Poulsen AH, Norgaard M, Sorensen HT, McLaughlin JK, Mortensen PB and Friis S: Cancer risk among users of neuroleptic medication: a population-based cohort study. Br J Cancer 95:934-939, 2006. (Pubitemid 44498111)
21. Cao X, Yeo G, Muotri AR, Kuvabara T and Gage FH: Noncoding RNAs in the mammalian central nervous system. An Rev Neurosci 29:77-103, 2006. (Pubitemid 44476840)
22. Lima RT, Busacca S, Almeida GM, Gaudino G, Fennel DA and Vasconcelos MH: MicroRNA regulation of core apoptosis pathways in cancer. Eur J Cancer 47:163-174, 2011.
23. Cho WC: MicroRNAs in cancer - from research to therapy. Biochim Biophys Acta 1805:209-217, 2010.
24. Fu LI, Wen X, Bao JK and Liu B: MicroRNA-modulated autophagic signaling networks in cancer. Int J Biochem Cell Biol 44:733-736, 2012.
25. Kim A, Reimers M, Maher B, Williamson V, McMichael O, McClay J, Van Den Oord E, Riley B, Kendler K and Vladimirov V: MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders. Schizophr Res 124:183-191, 2010.
26. Li ZY, Yang Y, Ming M and Liu B: Mitochondrial ROS generation for regulation of autophagic pathways in cancer. Biochem Biophys Res Commun 414:5-8, 2011.
27. Jian X, Xiao-yan Z, Bin H, Yu-feng Z, Bo K, Zhi-nong W and Xin N: Mir-204 regulate cardiomyocyte autophagy induced by hypoxia-reoxygenetion through LC3-II. Int J Cardiol 148:111-112, 2011.
28. Abraham D, Jackson N, Gundara JS, Zhao J, Gill AJ, Delbridge L, Robinson BG and Sidhu SB: MicroRNA profiling of sporadic and hereditary medullary thyroid cancer identifies predictors of nodal metastasis, prognosis, and potential therapeutic targets. Clin Cancer Res 17:4772-4781, 2011.
29. Wang G, Mao W and Zheng S: MicroRNA-183 regulates Ezrin expression in lung cancer cells. FEBS Lett 582:3663-3668, 2008.
30. Sarver A, Li L and Subramanian S: MicroRNA miR-183 functions as an oncogene by targeting the transcriptional factor ERG1 and promoting tymor cell migration. Cancer Res 70:9570-9580, 2010.
31. Babashah S and Soleimani M: The oncogenic and tumour suppressive roles of microRNAs in cancer and apoptosis. Eur J Cancer 47:1127-1137, 2011.
32. Zhu J, Feng Y, Ke Z, Yang Z, Zhou J, Huang X and Wang L: Down-regulation of miR-183 promotes migration and invasion of osteosarcoma by targeting Ezrin. Am J Pathol 180:2440-2451, 2012.
33. Li J, Liang S, Jin H, Xu C, Ma D and Lu X: Tiam1, negatively regulated by miR-22, miR-183 and miR-31, is involved in migration, invasion and viability of ovarian cancer cells. Oncol Rep 27:1835-1842, 2012.
34. Hermeking H: P53 enters the microRNA world. Cancer Cell 12:414-418, 2007. (Pubitemid 350046413)
35. Zhu S, Si ML, Wu H and Mo YY: MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). JBC 282:14328-14336, 2007. (Pubitemid 47100416)
36. Frankel LB, Christoffersen NR, Jakobsen A, Lindow M, Krogh A and Lund AH: Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J Biol Chem 283:1026-1033, 2008.
37. Perkins DO, Jeffries CD, Jarskog LF, Thomson JM, Woods K, Newman MA, Parker JS, Jim JP and Hammond SM: MicroRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder. Genome Biol 8:R27, 2007.
38. Abu-Elneel K, Liu T, Gazzaniga FS, Nishimura Y, Wall DP, Geschwind DH, Lao K and Kosik KS: Heterogenous dysregulation of microRNAs across the autism spectrum. Neurogenetics 9:153-161, 2008.
39. Junn E, Lee KW, Jeong BS, Chan TW, Imb J and Mouradian MM: Repression of alpha-synuclein expression and toxicity by microRNA-7. Proc Natl Acad Sci USA 106:13052-13057, 2009.
40. Cogswell J P, Ward J, Taylor A, Waters M, Shi Y, Cannon B, Kelnar K, Kemppainen J, Brown D, Chen C, Prinjha RK, Richardson JC, Saunders AM, Roses AD and Richards CA: Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimer Dis 14:27-41, 2008. (Pubitemid 352039013)